Work

Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Year: 2003

Type: article

Study design: Clinical Trial

Source: Cancer Biotherapy and Radiopharmaceuticals

DOI: 10.1089/108497803765036337

Authors: Gregory A. Wiseman, Bryan R. Leigh, William D. Erwin, Richard B. Sparks, Donald A. Podoloff, Russell J. Schilder, Nancy L. Bartlett, Stewart M. Spies, Antonio J. Grillo-López, Thomas E. Witzig, Christine A. White

Institutions: Mayo Clinic, Biogen (United States), Northwestern University, Oak Ridge National Laboratory, Fox Chase Cancer Center, Washington University in St. Louis

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1996566281

FWCI: 1.552

Cites: 18

Cited by: 30

Related to: 10